NEUROMAMA, LTD. Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2013-10-31..
Quick ratio
Overview →Financial period ending 2013-10-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2013-10-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | |
| Current obligations | 26.08K USD | Liabilities, Current |
| Cash and equivalents | (m) | |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2013-10-31 | (m) | $26.08K | (m) | (m) | (m) | (m) | (m) |
| 2013-07-31 | (m) | $17.53K | (m) | (m) | (m) | (m) | (m) |
| 2013-04-30 | (m) | $15.50K | (m) | (m) | (m) | (m) | (m) |
| 2013-01-31 | (m) | $14.44K | (m) | (m) | (m) | (m) | (m) |
| 2012-10-31 | (m) | $6.46K | (m) | (m) | (m) | (m) | (m) |
| 2012-07-31 | (m) | $5.49K | (m) | (m) | (m) | (m) | (m) |
| 2012-01-31 | (m) | $4.58K | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.